Showing results (1-10 of 123) with videos related to
Sort By:
Pageof 13
Cell Biochemistry and Function|September 29, 2020
SARS-COV-2 (COVID-19): Cellular and biochemical properties and pharmacological insights into new therapeutic developmentsHakan Parlakpinar, Mehmet GunataHeart Failure Reviews|December 12, 2022
Experimental heart failure models in small animalsMehmet Gunata, Hakan ParlakpinarImmunopharmacology and Immunotoxicology|August 20, 2021
Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugsHakan Parlakpinar, Mehmet GunataCell Biochemistry and Function|September 6, 2020
A review of myocardial ischaemia/reperfusion injury: Pathophysiology, experimental models, biomarkers, genetics and pharmacological treatmentMehmet Gunata, Hakan ParlakpinarMedeniyet Medical Journal|March 30, 2026
The Protective Effect of Carvacrol Against Isoproterenol-Induced Cardiotoxicity in RatsSeyhan Ayık, Hamza Dogukan Erfirat, Onural Ozhan, et al.Tissue & Cell|March 23, 2021
Protective effects of naringin on valproic acid-induced hepatotoxicity in ratsOmer Faruk Koroglu, Mehmet Gunata, Nigar Vardi, et al.Medicine International|June 1, 2026
Experimental atherosclerosis models in small animals (Review)Mehmet Ertugrul Balkar, Hakan ParlakpinarFundamental & Clinical Pharmacology|August 19, 2020
Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia-reperfusion necrosis in ratsOnural Ozhan, Hakan Parlakpinar, Ahmet AcetJournal of Chemical Neuroanatomy|September 28, 2011
Beneficial effects of chlorogenic acid on methotrexate-induced cerebellar Purkinje cell damage in ratsNigar Vardi, Hakan Parlakpinar, Burhan AtesFundamental & Clinical Pharmacology|July 14, 2020
Pharmacological agents under investigation in the treatment of coronavirus disease 2019 and the importance of melatoninHakan Parlakpinar, Seyhan Polat, Haci Ahmet AcetPageof 13